Literature DB >> 14983013

The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.

Jingyung Hur1, Jessica Chesnes, Kathryn R Coser, Roseanna S Lee, Peter Geck, Kurt J Isselbacher, Toshi Shioda.   

Abstract

Evidence has been accumulating that some estrogen-dependent human breast cancers require estrogen for not only proliferation but also survival. To obtain insights into the molecular mechanisms of apoptosis of breast cancer cells subjected to estrogen starvation or exposed to antiestrogens, we characterized changes in the gene expression profile of MCF-7/BUS human breast cancer cells and revealed a strong induction of Bik, a member of the BH3-only proapoptotic proteins. The Bik mRNA transcript and protein were strongly induced by estrogen starvation or exposure to fulvestrant, a pure antiestrogen that competes with the natural estrogens for binding to the estrogen receptors. This Bik induction preceded apoptotic cell death, which was blocked by zVAD-fmk, a pancaspase inhibitor. Amounts of the Bcl-2-related proteins, such as Bcl-2, Bcl-XL, or Bax, showed only marginal changes in the presence or absence of estrogens or antiestrogens. Suppression of Bik expression by using the small interfering RNA effectively blocked the fulvestrant-induced breast cancer cell apoptosis. These results indicate that Bik is induced in MCF-7/BUS cells in the absence of estrogen signaling and plays a critical role in the antiestrogen-provoked breast cancer cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983013      PMCID: PMC356954          DOI: 10.1073/pnas.0307337101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization.

Authors:  H Bahia; J N E Ashman; L Cawkwell; M Lind; J R T Monson; P J Drew; J Greenman
Journal:  Int J Oncol       Date:  2002-03       Impact factor: 5.650

2.  Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis.

Authors:  H Puthalakath; A Villunger; L A O'Reilly; J G Beaumont; L Coultas; R E Cheney; D C Huang; A Strasser
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

3.  Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer.

Authors:  Patricia P Reis; Silvia R Rogatto; Luiz P Kowalski; Inês N Nishimoto; Jair C Montovani; George Corpus; Jeremy A Squire; Suzanne Kamel-Reid
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

4.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

5.  The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.

Authors:  Silke Radetzki; Claus-Henning Köhne; Clarissa von Haefen; Bernhard Gillissen; Isrid Sturm; Bernd Dörken; Peter T Daniel
Journal:  Oncogene       Date:  2002-01-10       Impact factor: 9.867

6.  Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens.

Authors:  M E Burow; C B Weldon; Y Tang; J A McLachlan; B S Beckman
Journal:  J Steroid Biochem Mol Biol       Date:  2001-11       Impact factor: 4.292

7.  Systemic tumor suppression by the proapoptotic gene bik.

Authors:  Yiyu Zou; Hua Peng; Binhua Zhou; Yong Wen; Shao-Chun Wang; Eing-Mei Tsai; Mien-Chie Hung
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

Review 8.  Estrogen receptor and breast cancer.

Authors:  S Sommer; S A Fuqua
Journal:  Semin Cancer Biol       Date:  2001-10       Impact factor: 15.707

9.  Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53.

Authors:  Jaigi P Mathai; Marc Germain; Richard C Marcellus; Gordon C Shore
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

Review 10.  Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins.

Authors:  H Puthalakath; A Strasser
Journal:  Cell Death Differ       Date:  2002-05       Impact factor: 15.828

View more
  35 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  The endoplasmic reticulum (ER)-target protein Bik induces Hep3B cells apoptosis by the depletion of the ER Ca2+ stores.

Authors:  Xiaoping Zhao; Li Wang; Yan Sun; Ling Ye; Jian Lu; Yaozong Yuan; Guanxiang Qian; Shengfang Ge
Journal:  Mol Cell Biochem       Date:  2008-02-26       Impact factor: 3.396

3.  Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation.

Authors:  Hongbo Zhu; Wei Guo; Lidong Zhang; Shuhong Wu; Fuminori Teraishi; John J Davis; Fengqin Dong; Bingliang Fang
Journal:  Cancer Biol Ther       Date:  2005-07-06       Impact factor: 4.742

4.  Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).

Authors:  Hui Zhou; Yi Zhang; Yong Fu; Lauren Chan; Amy S Lee
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

5.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.

Authors:  Tsutomu Shimazu; Kurt Degenhardt; Alam Nur-E-Kamal; Junjie Zhang; Takeshi Yoshida; Yonglong Zhang; Robin Mathew; Eileen White; Masayori Inouye
Journal:  Genes Dev       Date:  2007-04-02       Impact factor: 11.361

6.  Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Authors:  Eva M Campion; Roya Hakimjavadi; Sinéad T Loughran; Susan Phelan; Sinéad M Smith; Brendan N D'Souza; Rosemary J Tierney; Andrew I Bell; Paul A Cahill; Dermot Walls
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 7.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

Review 8.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

9.  Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor.

Authors:  Kathryn R Coser; Ben S Wittner; Noël F Rosenthal; Sabrina C Collins; Antonia Melas; Shannon L Smith; Crystal J Mahoney; Keiko Shioda; Kurt J Isselbacher; Sridhar Ramaswamy; Toshi Shioda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-25       Impact factor: 11.205

10.  Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

Authors:  Vellareddy Anantharam; Elin Lehrmann; Arthi Kanthasamy; Yongjie Yang; Probal Banerjee; Kevin G Becker; William J Freed; Anumantha G Kanthasamy
Journal:  Neurochem Int       Date:  2007-02-23       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.